Agilent Technologies Pre-Paid Expenses 2010-2024 | A
Agilent Technologies pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
- Agilent Technologies pre-paid expenses for the quarter ending July 31, 2024 were $M, a NAN% increase year-over-year.
- Agilent Technologies pre-paid expenses for 2023 were $0B, a NAN% decline from 2022.
- Agilent Technologies pre-paid expenses for 2022 were $0B, a NAN% decline from 2021.
- Agilent Technologies pre-paid expenses for 2021 were $0B, a NAN% decline from 2020.
Agilent Technologies Annual Pre-Paid Expenses (Millions of US $) |
2023 |
$ |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
2016 |
$ |
2015 |
$ |
2014 |
$ |
2013 |
$ |
2012 |
$ |
2011 |
$ |
2010 |
$ |
2009 |
$ |
Agilent Technologies Quarterly Pre-Paid Expenses (Millions of US $) |
2024-07-31 |
|
2024-04-30 |
|
2024-01-31 |
|
2023-10-31 |
|
2023-07-31 |
|
2023-04-30 |
|
2023-01-31 |
|
2022-10-31 |
|
2022-07-31 |
|
2022-04-30 |
|
2022-01-31 |
|
2021-10-31 |
|
2021-07-31 |
|
2021-04-30 |
|
2021-01-31 |
|
2020-10-31 |
|
2020-07-31 |
|
2020-04-30 |
|
2020-01-31 |
|
2019-10-31 |
|
2019-07-31 |
|
2019-04-30 |
|
2019-01-31 |
|
2018-10-31 |
|
2018-07-31 |
|
2018-04-30 |
|
2018-01-31 |
|
2017-10-31 |
|
2017-07-31 |
|
2017-04-30 |
|
2017-01-31 |
|
2016-10-31 |
|
2016-07-31 |
|
2016-04-30 |
|
2016-01-31 |
|
2015-10-31 |
|
2015-07-31 |
|
2015-04-30 |
|
2015-01-31 |
|
2014-10-31 |
|
2014-07-31 |
|
2014-04-30 |
|
2014-01-31 |
|
2013-10-31 |
|
2013-07-31 |
|
2013-04-30 |
|
2013-01-31 |
|
2012-10-31 |
|
2012-07-31 |
|
2012-04-30 |
|
2012-01-31 |
|
2011-10-31 |
|
2011-07-31 |
|
2011-04-30 |
|
2011-01-31 |
|
2010-10-31 |
|
2010-07-31 |
|
2010-04-30 |
|
2010-01-31 |
|
2009-10-31 |
|
2009-07-31 |
|
2009-04-30 |
|
2009-01-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Electrical Test Equipment |
$38.407B |
$6.833B |
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|